This is the first report about the involvement of DNA vector of monoclonal antibody in host NK immune clearance and the use of delivery system based on DNA plasmid to guide the production of therapeutic mAb targeting tumor antigen PSMA in vivo. This evidence concerns the gene FOLH1 and neoplasm.